TrialTrials2013

Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction--a randomised placebo-controlled trial (KARE): study protocol.

Laurence J M Cross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.